OA11.04 Volrustomig + platinum doublet chemotherapy (CTx) in first-line non-small cell lung cancer (NSCLC): Phase 1b trial update
D.R. Spigel(Sarah Cannon), M-J. Ahn(Samsung Medical Center), M. Majem(Hospital de Sant Pau), L. Medina Rodríguez(Instituto de Investigación Biomédica de Málaga), K.H. Lee(Chungbuk National University), Enric Carcereny(Badalona Serveis Assistencials), Anna Hernández‐Aguilera(Instituto Oncológico Dr. Rosell), Amelia Insa(Hospital Clínico Universitario de Valencia), E.K. Cho(Gachon University), Benjamin Besse(Université Paris-Saclay), S.Y. Rha(Yonsei University Health System), Jared Weiss(University of North Carolina at Chapel Hill), M. D'Arcangelo(Azienda Unità Sanitaria Locale Della Romagna), S. Im(Seoul National University), S.-W. Kim(Ulsan College), Benedito A. Carneiro(Brown University), S.M. Gadgeel(Henry Ford Health System), Patrick Mitchell(AstraZeneca (United States)), Julie M. Asare(AstraZeneca (United States)), Shelby D. Gainer(AstraZeneca (United States)), Ikbel Achour(AstraZeneca (United States)), Deepa S. Subramaniam(AstraZeneca (United States)), Enriqueta Felip(Hebron University)
Cited by 8Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis